Found 1216 clinical trials
-
Accepting pediatric ages
-
For all genders
-
Currently Recruiting
Seeking Oklahomans who have been diagnosed with chronic or unstable angina.
Seeking Oklahomans who have been diagnosed with chronic or unstable angina.
- 256 views
- 08 Nov, 2020
- 1 location
-
Accepting pediatric ages
-
Accepting adults
-
For all genders
-
Currently Recruiting
TIGRIS
TIGRIS
- 120 views
- 23 Nov, 2020
- 1 location
-
Phase 3 trial
-
Accepting pediatric ages
-
For all genders
-
Currently Recruiting
Randomized, Double-blind, Evaluation in Secondary Stroke Prevention Comparing the EfficaCy and Safety of the Oral Thrombin Inhibitor Dabigatran Etexilate (110 mg or 150 mg, Oral b.i.d.) Versus Acetylsalicylic Acid (100 mg Oral q.d.) in Patients With Embolic Stroke of Undetermined Source (RESPECT ESUS)
Randomized, Double-blind, Evaluation in Secondary Stroke Prevention Comparing the EfficaCy and Safety of the Oral Thrombin Inhibitor Dabigatran Etexilate (110 mg or 150 mg, Oral b.i.d.) Versus Acetylsalicylic Acid (100 mg Oral q.d.) in Patients With Embolic Stroke of Undetermined Source (RESPECT ESUS)
- 76 views
- 08 Nov, 2020
- 1 location
-
For all genders
-
Currently Recruiting
ABSORB III - A Clinical Evaluation of Absorbâ„¢ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects with de novo Native Coronary Artery Lesions Absorbâ„¢ is an investigational bioabsorbable vascular scaffold manufactured by Abbott. Absorbâ„¢ is referred to as a scaffold to indicate that it is a temporary structure.
ABSORB III - A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects with de novo Native Coronary Artery Lesions Absorb™ is an investigational bioabsorbable vascular scaffold manufactured by Abbott. Absorb™ is referred to as a scaffold to indicate that it is a …
- 120 views
- 08 Nov, 2020
- 1 location
-
Accepting pediatric ages
-
Accepting adults
-
For all genders
-
Currently Recruiting
Do you have heart disease or diabetes? Lowering cholesterol lowers risk of heart attack or stroke.
Do you have heart disease or diabetes? Lowering cholesterol lowers risk of heart attack or stroke.
- 334 views
- 08 Nov, 2020
- 2 locations
-
Phase 4 trial
-
Accepting Seniors
-
Accepting adults
-
For all genders
-
Currently Recruiting
The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
- 102 views
- 08 Nov, 2020
- 1 location
-
Phase 4 trial
-
Accepting pediatric ages
-
Accepting adults
-
For all genders
-
Currently Recruiting
NAC-MD-01 Hypertension study for patients with stage 1 or stage 2 essential hypertension
NAC-MD-01 Hypertension study for patients with stage 1 or stage 2 essential hypertension
- 552 views
- 08 Nov, 2020
- 1 location
-
Phase 3 trial
-
For all genders
-
Currently Recruiting
ODYSSEY OUTCOME STUDY - A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome
ODYSSEY OUTCOME STUDY - A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome
- 94 views
- 08 Nov, 2020
- 1 location
-
Accepting pediatric ages
-
For all genders
-
Currently Recruiting
CASCADE FH Registry: Cascade Screening for Awareness and Detection of Familial Hypercholesterolemia
CASCADE FH Registry: Cascade Screening for Awareness and Detection of Familial Hypercholesterolemia
- 434 views
- 23 Nov, 2020
- 1 location
-
Accepting pediatric ages
-
Accepting adults
-
For all genders
-
Currently Recruiting
COBRA PzF
COBRA PzF
- 34 views
- 08 Nov, 2020
- 1 location